Research Articles | Page 17 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Germline mutations in MDS/AML predisposition disorders Mar 2021 Current opinion in hematology Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)
Current Therapeutic Landscape in Lower Risk Myelodysplastic Syndromes May 2023 Current Treatment Options in Oncology Myelodysplastic Syndromes (MDS)
Clonal selection in therapy related myelodysplastic syndromes and acute myeloid leukemia under azacitidine treatment Jan 2020 European Journal of Haematology Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)
Beneficial effects of eculizumab regardless of prior transfusions or bone marrow disease: Results of the International PNH Registry Jul 2020 European Journal of Haematology Paroxysmal Nocturnal Hemoglobinuria (PNH)
Platelet transfusions and predictors of bleeding in patients with myelodysplastic syndromes Jul 2023 European Journal of Haematology Myelodysplastic Syndromes (MDS)
One-year outcomes from a phase 3 randomized trial of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria who received prior eculizumab Dec 2020 European Journal of Haematology Paroxysmal Nocturnal Hemoglobinuria (PNH)
Nationwide study of eculizumab in paroxysmal nocturnal hemoglobinuria: Evaluation of treatment indications and outcomes Jun 2023 European Journal of Haematology Paroxysmal Nocturnal Hemoglobinuria (PNH)
Cyclosporine plus eltrombopag in the treatment of aplastic anemia with or without antithymocyte immunoglobulin: A multicenter real-world retrospective study Jun 2023 European Journal of Haematology Aplastic Anemia
Cyclosporine Enhances the Sensitivity to Lenalidomide in MDS/AML in Vitro Jun 2020 Experimental Hematology Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)
Cyclosporine Enhances the Sensitivity to Lenalidomide in MDS/AML in Vitro May 2020 Experimental Hematology Myelodysplastic Syndromes (MDS)